13D Filing: SC Fundamental Value Fund, L.P. and Aviragen Therapeutics Inc. (AVIR)

Page 4 of 12

Page 4 of 12 – SEC Filing

CUSIP
No. 053761102
13D/A Page
4 of 11 Pages
         
1.

names
of reporting persons

i.r.s.
identification no. of above persons (entities only)

 

Peter
M. Collery

 

2. check
the appropriate box if a  group*
(a)
x
(b) o
3.

sec
use only

 

4.

sources
of funds

 

OO/PF

5. check
box if disclosure of legal proceedings is required pursuant to item 2(
d)
or 2(
e)         
      o
6.

citizenship
or place of organization

UNITED STATES OF AMERICA

number
of

shares
7. sole
voting power     
0
beneficially
owned by
8. shared
voting power    
1,868,143
each
reporting
9. sole
dispositive power    
0
person
with
10. shared
dispositive power    
1,868,143
11. aggregate
amount beneficially owned by each reporting person    
1,868,143
12. check
box if the aggregate amount in row (11) excludes certain shares *         
      o
13. percent
of class represented by amount in row 11     
4.83%
14.

type
of reporting person*

IN

Follow Vaxart Inc. (NASDAQ:VXRT)

Page 4 of 12